Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Ribosomal protein L26 pseudogene 28 (RPL26P28) is a human processed pseudogene found on chromosome 10p15.1[6][7][8]. Pseudogenes are genomic DNA sequences similar to normal genes but typically non-functional; they do not encode functional proteins, and in most cases, are not transcribed or translated. RPL26P28 shares sequence similarity to ribosomal protein L26 (RPL26), which is a component of the large ribosomal 60S subunit involved in protein synthesis, but RPL26P28 does not code for an active ribosomal protein[1][8]. There is no evidence that RPL26P28 is involved in regulatory, disease, or drug response processes. In summary, RPL26P28 is a non-coding genetic element classified as a pseudogene, with no known molecular function, therapeutic targeting, or clinical biomarker use.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Ribosomal protein L26 pseudogene 28 (RPL26P28).